Fermentation goes mainstream
Fermentation-based foods and proteins are surging in 2026 — but industry experts warn scaling from lab to industrial production is the big bottleneck, with variability and consistency top concerns for safety and cost [ ]. Expect rapid growth in allergen and regulatory testing markets as fermentation‑derived proteins move from niche to mainstream [].
Ohly’s global lead expert Alessandro Ciranna released a technical briefing on March 13, 2026, identifying nutrient inconsistency as a primary cause of batch failure, reduced yield and throughput delays in industrial fermentation. foodanddrinktechnology.com The briefing names seasonality, geography and varying brewing processes as drivers of amino‑acid and micronutrient swings and recommends switching to proprietary yeast‑derived bio‑nutrients under end‑to‑end manufacturing control to regain reproducibility. foodanddrinktechnology.com Independent industry analysis warns scale‑up is a systemic failure mode—“scale is a regime change,” with downstream steps like extraction and drying turning lab wins into commercial losses, according to a January 2026 industry essay on biotech scale‑up. berubebioventures.com Market research firms are already pricing that downstream risk into testing demand: The Business Research Company reports the food allergen testing market at $1.11 billion in 2025 and projects $1.22 billion in 2026, rising to $1.71 billion by 2030. thebusinessresearchcompany.com Other analysts show similar expansion: Mordor Intelligence forecasts the sector growing from roughly $1.18 billion in 2025 to $1.35 billion in 2026 as manufacturers move from end‑line checks to in‑process verification. mordorintelligence.com
